Antonio Ferrer, Director of the Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE) has positively valued the conference that took place today, December 21, in which promising young people in biotechnology research have presented their work. The day began at 10:00 a.m. on Thursday, December 21 in the von Humboldt Room of the Torregaitán building (Elche Campus). The people who have participated are Mila Collados Rodríguez, Melissa Belló Pérez, Enrique Velasco, Alba Boix and Oriol Juanola. From the IDiBE they wanted to highlight each of the profiles:

Mila Collados Rodríguez obtained her PhD in Biochemistry at the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences in Warsaw (Poland). Since 2018 he has worked at the Center for Virus Research at the University of Glasgow (UK) on intrinsic and innate immunity.

Melissa Belló Pérez carried out her doctoral thesis studying the role of c-reactive protein in the immune response of fish against rhabdoviruses. She has worked at the CSIC with Drs. Luis Enjuanes and Isabel Sola on the identification of the virulence factors of human coronaviruses and on the design of a vaccine against SARS-CoV-2, of which she is the inventor.

Enrique Velasco works at the University of Leuven as a Marie Curie postdoctoral researcher, investigating the neurobiological mechanisms of pain in ion channels. In addition, he directs the scientific research and consulting group NiP (Neuroscience in Physiotherapy).

Alba Boix has been working on studying the relationships between the human microbiome and health, including the transfer of microorganisms from the mother to the newborn during childbirth, and the protective role of the microbiome against different diseases since 2020 at the Icahn School of Medicine at the Mount Hospital. Sinai in New York.

Oriol Juanola has completed a 3-year postdoc at the Università della Svizzera Italiana (Switzerland) and, recently, has returned to Rubén Francés’ group at the UMH. His research work has focused, for 10 years, on studying the intestine-liver axis in the progression of chronic liver disease.

For Antonio Ferrer, “attracting and retaining talent is essential for carrying out excellent science and this event is a unique opportunity to establish contact with new people who meet these criteria to encourage their incorporation into the IDiBE.”

The news has been published in Diario Información.